Expression of major histocompatibility complex class I proteins and their antigen processing chaperones in mouse embryonic stem cells from fertilized and parthenogenetic embryos

Tissue Antigens

Volumn 72, Issue 5, 2008, Pages 448-457

  Lampton, P W ^a   Crooker, R J ^a   Newmark, J A ^a   Warner, C M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Antigen processing chaperones; Embryonic stem cells; MHC class I; Parthenogenesis

Indexed keywords

CHAPERONE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN H 2K; PROTEIN QA 2; TAPASIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; MOUSE; NONHUMAN; PARTHENOGENESIS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CALNEXIN; EMBRYONIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON-GAMMA; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR CHAPERONES; PARTHENOGENESIS; RNA, MESSENGER; UP-REGULATION;

EID: 54049153172     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01132.x     Document Type: Article

References (49)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998 : 282 : 1145 7.
2. Wang Y, Yates F, Naveiras O, Ernst P, Daley GQ. Embryonic stem cell-derived hematopoietic stem cells. Proc Natl Acad Sci U S A 2005 : 102 : 19081 6.
3. Keirstead HS, Nistor G, Bernal G et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005 : 25 : 4694 705.
4. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart. Nature 2008 : 453 : 322 9.
5. Allen ND, Barton SC, Hilton K, Norris ML, Surani MA. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 1994 : 120 : 1473 82.
6. Strelchenko N, Verlinsky O, Kukharenko V, Verlinsky Y. Morula-derived human embryonic stem cells. Reprod Biomed Online 2004 : 9 : 623 9.
7. Chung Y, Klimanskaya I, Becker S et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 2006 : 439 : 216 9.
8. Munsie MJ, Michalska AE, O'Brien CM, Trounson AO, Pera MF, Mountford PS. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol 2000 : 10 : 989 92.
9. Kim K, Lerou P, Yabuuchi A et al. Histocompatible embryonic stem cells by parthenogenesis. Science 2007 : 315 : 482 6.
10. Kono T, Obata Y, Wu Q et al. Birth of parthenogenetic mice that can develop to adulthood. Nature 2004 : 428 : 860 4.
11. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 1971 : 134 : 83 102.
12. George T, Yu YY, Liu J et al. Allorecognition by murine natural killer cells: lysis of T-lymphoblasts and rejection of bone-marrow grafts. Immunol Rev 1997 : 155 : 29 40.
13. Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002 : 99 : 9864 9.
14. Abdullah Z, Saric T, Kashkar H et al. Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J Immunol 2007 : 178 : 3390 9.
15. Magliocca JF, Held IK, Odorico JS. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev 2006 : 15 : 707 17.
16. Tian L, Catt JW, O'Neill C, King NJ. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol Reprod 1997 : 57 : 561 8.
17. Drezen JM, Babinet C, Morello D. Transcriptional control of MHC class I and beta 2-microglobulin genes in vivo. J Immunol 1993 : 150 : 2805 13.
18. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 2005 : 207 : 145 57.
19. Garbi N, Tan P, Diehl AD et al. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice. Nat Immunol 2000 : 1 : 234 8.
20. Van Kaer L, Ashton-Rickardt PG, Ploegh HL, Tonegawa S. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells. Cell 1992 : 71 : 1205 14.
21. Lampton PW, Goldstein CY, Warner CM. The role of tapasin in MHC class I protein trafficking in embryos and T cells. J Reprod Immunol 2008 : 78 : 28 39.
22. Ke X, Warner CM. Regulation of Ped gene expression by TAP protein. J Reprod Immunol 2000 : 46 : 1 15.
23. Comiskey M, Domino KE, Warner CM. HLA-G is found in lipid rafts and can act as a signaling molecule. Hum Immunol 2007 : 68 : 1 11.
24. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001 : 29 : e45.
25. Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002 : 32 : 1372 4, 1376, 1378-9.
26. Bonde S, Zavazava N. Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 2006 : 24 : 2192 201.
27. Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 2004 : 22 : 448 56.
28. Warner CM, Gollnick SO, Flaherty L, Goldbard SB. Analysis of Qa-2 antigen expression by preimplantation mouse embryos: possible relationship to the preimplantation-embryo-development (Ped) gene product. Biol Reprod 1987 : 36 : 611 6.
29. McElhinny AS, Kadow N, Warner CM. The expression pattern of the Qa-2 antigen in mouse preimplantation embryos and its correlation with the Ped gene phenotype. Mol Hum Reprod 1998 : 4 : 966 71.
30. Warner CM, Newmark JA, Comiskey M et al. Genetics and imaging to assess oocyte and preimplantation embryo health. Reprod Fertil Dev 2004 : 16 : 729 41.
31. Chiang EY, Henson M, Stroynowski I. The nonclassical major histocompatibility complex molecule Qa-2 protects tumor cells from NK cell- and lymphokine-activated killer cell-mediated cytolysis. J Immunol 2002 : 168 : 2200 11.
32. Abarca-Heidemann K, Friederichs S, Klamp T, Boehm U, Guethlein LA, Ortmann B. Regulation of the expression of mouse TAP-associated glycoprotein (tapasin) by cytokines. Immunol Lett 2002 : 83 : 197 207.
33. Bikoff EK, Jaffe L, Ribaudo RK, Otten GR, Germain RN, Robertson EJ. MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon. Nature 1991 : 354 : 235 8.
34. Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells. Cancer Res 2001 : 61 : 1095 9.
35. Cabrera CM, Nieto A, Cortes JL et al. The low rate of HLA class I molecules on the human embryonic stem cell line HS293 is associated with the APM components' expression level. Cell Biol Int 2007 : 31 : 1072 8.
36. Williams DB. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci 2006 : 119 : 615 23.
37. Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006 : 24 : 221 9.
38. Koch CA, Geraldes P, Platt JL. Immunosuppression by embryonic stem cells. Stem Cells 2008 : 26 : 89 98.
39. Wu D, Boyd AS, Wood KJ. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege, but still represent novel targets of immune attack. Stem Cells 2008 : 26 : 1939 50.
40. Lengerke C, Kim K, Lerou P, Daley GQ. Differentiation potential of histocompatible parthenogenetic embryonic stem cells. Ann N Y Acad Sci 2007 : 1106 : 209 18.
41. Jiang H, Sun B, Wang W et al. Activation of paternally expressed imprinted genes in newly derived germline-competent mouse parthenogenetic embryonic stem cell lines. Cell Res 2007 : 17 : 792 803.
42. Wilmut I. Embryo stem cells from parthenotes and embryos produced by nuclear transfer: the distinction between them and their potential value in cell therapy. Cloning Stem Cells 2007 : 9 : 291 2.
43. Revazova ES, Turovets NA, Kochetkova OD et al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2008 : 10 : 11 24.
44. Revazova ES, Turovets NA, Kochetkova OD et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007 : 9 : 432 49.
45. Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005 : 366 : 2019 25.
46. Arcellana-Panlilio MY, Schultz GA. Temporal and spatial expression of major histocompatibility complex class I H-2K in the early mouse embryo. Biol Reprod 1994 : 51 : 169 83.
47. Wu L, Exley GE, Warner CM. Differential expression of Ped gene candidates in preimplantation mouse embryos. Biol Reprod 1998 : 59 : 941 52.
48. Pearce RB, Trigler L, Svaasand EK, Peterson CM. Polymorphism in the mouse Tap-1 gene. Association with abnormal CD8+ T cell development in the nonobese nondiabetic mouse. J Immunol 1993 : 151 : 5338 47.
49. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003 : 31 : e154.